Results 11 to 20 of about 2,747,113 (394)

High prevalence of chronic kidney disease and its related risk factors in rural areas of Northeast Thailand [PDF]

Scientific Reports, 2022
In Thailand, chronic kidney disease (CKD) screening was reported in 2009 with an overall prevalence of 17.5% and the highest at 22.2% in the northeastern region.
Ubon Cha’on, Patcharaporn Tippayawat, Nattaya Sae-ung, Porntip Pinlaor, Wichien Sirithanaphol, Ampornpan Theeranut, Kriang Tungsanga, Prathana Chowchuen, Amod Sharma, Supakit Boonlakron, Sirirat Anutrakulchai   +10 more
doaj   +2 more sources

Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 [PDF]

The Lancet, 2020
BACKGROUND: Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries.
Boris Caroline A Andrew S Mari Amir Molla Oladimeji M Mo Bikbov Purcell Levey Smith Abdoli Abebe Adebayo Af, B. Bikbov, Caroline A. Purcell, A. Levey, Mari Smith, Amir Abdoli, Molla Abebe, O. Adebayo, M. Afarideh, Sachin Agarwal, Marcela Agudelo-Botero, E. Ahmadian, Z. Al-Aly, V. Alipour, A. Almasi-Hashiani, Rajaa Al-Raddadi, N. Alvis-Guzmán, S. Amini, Tudorel Andrei, C. Andrei, Zewudu Andualem, Mina Anjomshoa, J. Arabloo, A. Ashagre, Daniel Asmelash, Z. Ataro, Maha Moh’d Wahbi Atout, M. Ayanore, A. Badawi, A. Bakhtiari, S. Ballew, A. Balouchi, Maciej Banach, S. Barquera, Sanjay Basu, Mulat Tirfie Bayih, Neeraj Bedi, A. Bello, I. Benseñor, Ali Bijani, A. Boloor, A. Borzì, L. Cámera, J. Carrero, F. Carvalho, Franz Castro, F. Catalá-López, Alex R. Chang, K. Chin, Sheng-Chia Chung, Massimo Cirillo, Ewerton Cousin, L. Dandona, R. Dandona, A. Daryani, R. Das Gupta, F. M. Demeke, Gebre Teklemariam Demoz, Desilu Mahari Desta, H. Do, B. Duncan, A. Eftekhari, A. Esteghamati, S. S. Fatima, João Fernandes, E. Fernandes, F. Fischer, M. Freitas, M. Gad, Gebreamlak Gebremedhn Gebremeskel, B. M. Gebresillassie, Birhanu Geta, M. Ghafourifard, A. Ghajar, N. Ghith, P. Gill, I. Ginawi, R. Gupta, N. Hafezi-Nejad, Arvin Haj-Mirzaian, A. Haj-Mirzaian, Ninuk Hariyani, M. Hasan, Milad Hasankhani, A. Hasanzadeh, H. Y. Hassen, Simon Iain Hay, B. Heidari, C. Herteliu, C. L. Hoang, M. Hosseini, M. Hostiuc, S. Irvani, S. Islam, Nader Jafari Balalami, S. James, S. Jassal, V. Jha, J. Jonas, F. Joukar, J. Jozwiak, Alia Kabir, Amaha Kahsay, A. Kasaeian, T. Kassa, Hagazi Gebremedhin Kassaye, Yousef S. Khader, Rovshan Khalilov, E. Khan, M. S. Khan, Y. Khang, A. Kisa, C. Kovesdy, Barthelemy Kuate Defo, G. Kumar, A. Larsson, L. Lim, Alan D. Lopez, P. Lotufo, A. Majeed, R. Malekzadeh, Winfried März, Anthony Masaka, H. Meheretu, T. Miazgowski, Andreea Mirica, E. Mirrakhimov, P. Mithra, B. Moazen, D. K. Mohammad, R. Mohammadpourhodki, S. Mohammed, A. Mokdad, Linda Morales, Ilais Moreno Velásquez, Seyyed Meysam Mousavi, S. Mukhopadhyay, J. Nachega, Girish N. Nadkarni, J. R. Nansseu, G. Natarajan, J. Nazari, B. Neal, R. Negoi, C. Nguyen, Rajan Nikbakhsh, J. Noubiap, C. Nowak, A. Olagunju, Alberto Ortiz, M. Owolabi, R. Palladino, M. Pathak, H. Poustchi, S. Prakash, N. Prasad, A. Rafiei, S. Raju, K. Ramezanzadeh, S. Rawaf, D. Rawaf, Lal B Rawal, R. Reiner, A. Rezapour, D. Ribeiro, L. Roever, D. Rothenbacher, G. M. Rwegerera, Seyedmohammad Saadatagah, Saeed Safari, B. Sahle, Hosni Salem, J. Sanabria, I. Santos, Arash Sarveazad, M. Sawhney, E. Schaeffner, M.I. Schmidt, A. Schutte, S. Sepanlou, M. Shaikh, Z. Sharafi, M. Sharif, Amrollah Sharifi, D. Silva, Jasvinder A. Singh, N. P. Singh, M. M. Sisay, A. Soheili, I. Sutradhar, B. Teklehaimanot, B. E. Tesfay, Getnet Teshome, J. Thakur, M. Tonelli, Khanh B. Tran, B. Tran, Candide Tran Ngoc, I. Ullah, Pascual Valdez, S. Varughese, T. Vos, L. G. Vu, Yasir Waheed, A. Werdecker, H. F. Wolde, A. Wondmieneh, Sarah Wulf Hanson, Tomohide Yamada, Yigizie Yeshaw, N. Yonemoto, H. Yusefzadeh, Z. Zaidi, Leila Zaki, S. Zaman, N. Zamora, A. Zarghi, Kaleab Alemayehu Zewdie, J. Ärnlöv, J. Coresh, N. Perico, G. Remuzzi, C. Murray, T. Vos   +223 more
semanticscholar   +6 more sources

Empagliflozin in Patients with Chronic Kidney Disease

New England Journal of Medicine, 2022
Background This study, the EMPA-KIDNEY trial, was designed to assess the effects of empagliflozin in a broad range of patients with chronic kidney disease (CKD) at risk of progression. Methods We randomly assigned 6609 participants to empagliflozin (10mg
W. Herrington, N. Staplin, C. Wanner, J. B. Green, S. Hauske, J. Emberson, D. Preiss, P. Judge, Kaitlin J. Mayne, S. Ng, E. Sammons, D. Zhu, M. Hill, W. Stevens, K. Wallendszus, S. Brenner, A. Cheung, Zhi-Hong Liu, Jing Li, L. Hooi, Wen Liu, T. Kadowaki, M. Nangaku, A. Levin, D. Cherney, A. Maggioni, R. Pontremoli, R. Deo, S. Goto, X. Rosselló, Katherine R. Tuttle, D. Steubl, M. Petrini, D. Massey, Jens Eilbracht, M. Brueckmann, M. Landray, C. Baigent, R. Haynes   +38 more
semanticscholar   +1 more source

CKDNET, a quality improvement project for prevention and reduction of chronic kidney disease in the Northeast Thailand

BMC Public Health, 2020
Background The incidence of chronic kidney disease (CKD) is high in the Northeast Thailand compared to other parts of the country. Therefore, a broad program applying all levels of care is inevitable.
Ubon Cha’on, Kanok Wongtrangan, Bandit Thinkhamrop, Sajja Tatiyanupanwong, Chulaporn Limwattananon, Cholatip Pongskul, Thanachai Panaput, Chalongchai Chalermwat, Worachart Lert-itthiporn, Amod Sharma, Sirirat Anutrakulchai, CKDNET group   +11 more
doaj   +1 more source

Adiponectin in Chronic Kidney Disease [PDF]

International Journal of Molecular Sciences, 2020
Adiponectin is the adipokine associated with insulin sensitization, reducing liver gluconeogenesis, and increasing fatty acid oxidation and glucose uptake. Adiponectin is present in the kidneys, mainly in the arterial endothelium and smooth muscle cells, as well as in the capillary endothelium, and might be considered as a marker of many negative ...
Jarosław Przybyciński, Violetta Dziedziejko, Kamila Puchałowicz, Leszek Domański, Andrzej Pawlik   +4 more
openaire   +2 more sources

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

Diabetes Care, 2022
People with diabetes and chronic kidney disease (CKD) are at high risk for kidney failure, atherosclerotic cardiovascular disease, heart failure, and premature mortality. Recent clinical trials support new approaches to treat diabetes and CKD.
I. D. de Boer, K. Khunti, Tami Sadusky, K. Tuttle, Joshua J. Neumiller, Connie M. Rhee, Sylvia E. Rosas, P. Rossing, G. Bakris   +8 more
semanticscholar   +1 more source

Antiphospholipid syndrome: A disease of protean face [PDF]

Journal of Nephropathology, 2013
Background: Antiphospholipid syndrome (APS) is a systemic disorder characterizes by recurrent arterial and venous thrombosis and/or pregnancy miscarriages and positive test for antiphospholipid antibodies.
Mohammadreza Ardalan, Amir Vahedi
doaj   +1 more source

A Machine Learning Methodology for Diagnosing Chronic Kidney Disease

IEEE Access, 2023
Chronic kidney disease (CKD) is a global health problem with high morbidity and mortality rate, and it induces other diseases. Since there are no obvious symptoms during the early stages of CKD, patients often fail to notice the disease.
Jiongming Qin, Lin Chen, Yuhua Liu, Chuanjun Liu, Changhao Feng, Bin Chen   +5 more
semanticscholar   +1 more source

Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease

Circulation Research, 2023
Hypertension is the leading modifiable cause of premature death and hence one of the global targets of World Health Organization for prevention. Hypertension also affects the great majority of patients with chronic kidney disease (CKD). Both hypertension
M. Burnier, A. Damianaki
semanticscholar   +1 more source

Troponins, Acute Coronary Syndrome and Renal Disease: From Acute Kidney Injury Through End-stage Kidney Disease [PDF]

, 2019
The diagnosis of acute coronary syndromes (ACS) is heavily dependent on cardiac biomarker assays, particularly cardiac troponins. ACS, particularly non-ST segment elevation MI, are more common in patients with acute kidney injury, chronic kidney disease (
Banerjee, A, Banerjee, D, Ferrett, C
core   +2 more sources